1,243 results on '"Ji, Jiafu"'
Search Results
2. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
3. Long-term outcomes of laparoscopic versus open total gastrectomy in patients with advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study
4. The deubiquitinase USP15 drives malignant progression of gastric cancer through glucose metabolism remodeling
5. Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
6. Safety and short-term outcomes of a modified valvuloplastic esophagogastrostomy versus gastric tube anastomosis after laparoscopy-assisted proximal gastrectomy: a retrospective cohort study
7. Pre- and Post-treatment Double-Sequential-Point Dynamic Radiomic Model in the Response Prediction of Gastric Cancer to Neoadjuvant Chemotherapy: 3-Year Survival Analysis
8. Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
9. Associations of incident female breast cancer with long-term exposure to PM2.5 and its constituents: Findings from a prospective cohort study in Beijing, China
10. Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction
11. Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China
12. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
13. E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
14. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
15. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer
16. Piceatannol enhances Beclin-1 activity to suppress tumor progression and its combination therapy strategy with everolimus in gastric cancer
17. Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
18. Associations of Annual Hospital and Surgeon Volume with Patient Outcomes After Gastrectomy: A Systematic Review and Meta-analysis
19. Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
20. The N6-methyladenine DNA demethylase ALKBH1 promotes gastric carcinogenesis by disrupting NRF1 binding capacity
21. Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer
22. Efficacy of the Oral Administration of Maltodextrin Fructose Before Major Abdominal Surgery: A Prospective, Multicenter Clinical Study
23. Multi‐regional sequencing reveals the genetic and immune heterogeneity of non‐cancerous tissues in gastric cancer
24. Reproducible and high sample throughput isomiR next-generation sequencing for cancer diagnosis.
25. Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
26. Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy
27. Interpretable tumor differentiation grade and microsatellite instability recognition in gastric cancer using deep learning
28. High-fat diet alleviates colitis by inhibiting ferroptosis via solute carrier family seven member 11
29. Omitting nasogastric tube placement after gastrectomy does not enhance postoperative recovery: a propensity score matched analysis
30. Early Diagnosis of Anastomotic Leakage After Gastric Cancer Surgery Via Analysis of Inflammatory Factors in Abdominal Drainage
31. DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance
32. Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials
33. Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study
34. Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer
35. Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
36. ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer.
37. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)
38. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy
39. Comparison of uncut Roux-en-Y anastomosis and Billroth-II with Braun anastomosis after distal gastrectomy
40. Reducing the global cancer burden with gastrointestinal screening: China’s 30 years practice
41. Label‐Free Virtual Peritoneal Lavage Cytology via Deep‐Learning‐Assisted Single‐Color Stimulated Raman Scattering Microscopy
42. Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer
43. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
44. Construction and Validation of a Risk-Scoring Model that Preoperatively Predicts Lymph Node Metastasis in Early Gastric Cancer Patients
45. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach
46. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy
47. Proteomics provides individualized options of precision medicine for patients with gastric cancer
48. Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer
49. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial
50. Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.